• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Fundbox Appoints Hilliard Terry to Board of Directors

    6/22/21 12:00:00 PM ET
    $UPST
    $TGH
    $A
    $TLGA
    Finance: Consumer Services
    Finance
    Diversified Commercial Services
    Consumer Discretionary
    Get the next $UPST alert in real time by email

    SAN FRANCISCO, CA, June 22, 2021 (GLOBE NEWSWIRE) -- Fundbox, the financial platform for small businesses, announced today that it has appointed Hilliard Terry to its Board of Directors. Mr. Terry is an experienced executive leader, corporate board member and advisor to private equity backed portfolio companies.  

    Mr. Terry currently serves on the board of directors of Umpqua Holdings Corporation (NASDAQ:UMPQ), a financial services company. He also serves on the board of directors of Upstart Holdings, Inc. (NASDAQ:UPST), a leading artificial intelligence consumer lending platform, and on the board of TLG Acquisition One Corporation (NYSE:TLGA), a special purpose acquisition company.

    "Hilliard is an accomplished public company CFO and a seasoned board member with an impressive record of achievement at the intersection of technology, finance, and banking," said Prashant Fuloria, CEO of Fundbox. "We are thrilled to benefit from his operating and board experience in this time of opportunity and growth post-COVID."

    Mr. Terry has recently served as an advisor to private companies and previously as Executive Vice President and Chief Financial Officer of Textainer (NYSE:TGH). Prior to Textainer, Mr. Terry was Vice President and Treasurer at Agilent Technologies (NYSE:A), and was the Head of Investor Relations during their IPO and subsequent spin-off from Hewlett-Packard. Before joining Agilent, he worked in marketing and investor relations for HP's VeriFone subsidiary. Mr. Terry has also held positions in investor relations and investment banking with Kenetech Corporation and Goldman, Sachs & Co., respectively. He is a qualified financial expert with operating experience and in-depth knowledge of accounting, treasury, investor relations, financial planning & analysis, risk management and corporate development.

    "Through their AI-powered platform, Fundbox is providing access to credit for a much broader community of small businesses, a sector that has been underserved in the past. This is critically important and fundamentally different from anything that has ever been done before," said Mr. Terry. "There is a massive market opportunity ahead and I look forward to rolling up my sleeves and diving into areas like governance and compliance, which are critical fields of investment for a company at this stage." 

    The company is poised for massive growth as the small business economy recovers and expands post-COVID. Recent research has shown that Americans started 4.4 million businesses in 2020, a 24% increase from the year prior, and the first time in history that new businesses have increased during a recession. 

    Fundbox provides access to financial tools that enable small business owners to cover business-critical operating expenses. Their AI technology has enabled the company to scale quickly through automation while increasing access to capital through superior predictions and credit decisions. Fundbox's process is fully automated, and 99% of their decisions are made without human intervention.

    About Fundbox

    Fundbox is a financial platform for small businesses. The company is on a mission to unlock growth for small businesses by providing fast and easy access to financial tools and working capital solutions.  Fundbox has connected with nearly 300,000 businesses, unlocked over $2B in working capital, and invested $100M into its AI platform, gaining deep insights into the small business ecosystem.

    The company has received numerous awards including the prestigious Forbes Best Startup Employers and AI 50, Red Herring Top North American 250, CB Insights Fintech 250, and Fintech Breakthrough Awards. Founded in 2013, Fundbox currently has 200+ employees and offices in San Francisco, CA; Dallas, TX; and Tel Aviv, Israel.



    Liz Berman
    Allison+Partners
    908-566-2090
    [email protected]
    
    Get the next $UPST alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $UPST
    $TGH
    $A
    $TLGA

    CompanyDatePrice TargetRatingAnalyst
    Agilent Technologies Inc.
    $A
    12/9/2025$170.00Buy
    Goldman
    Agilent Technologies Inc.
    $A
    12/2/2025$270.00Overweight
    Morgan Stanley
    Agilent Technologies Inc.
    $A
    10/8/2025$165.00Buy
    Rothschild & Co Redburn
    Agilent Technologies Inc.
    $A
    10/8/2025$170.00Neutral → Buy
    UBS
    Upstart Holdings Inc.
    $UPST
    8/20/2025$88.00Neutral → Overweight
    Analyst
    Upstart Holdings Inc.
    $UPST
    7/14/2025$71.00Sell
    Goldman
    Upstart Holdings Inc.
    $UPST
    6/24/2025$75.00Overweight
    Piper Sandler
    Upstart Holdings Inc.
    $UPST
    6/12/2025$55.00Equal-Weight
    Stephens
    More analyst ratings

    $UPST
    $TGH
    $A
    $TLGA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Technology Offier Gu Paul bought $3,922,800 worth of shares (100,000 units at $39.23) (SEC Form 4)

    4 - Upstart Holdings, Inc. (0001647639) (Issuer)

    11/13/25 4:31:11 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    SEC Form 4 filed by Gonsalves Rodney (Amendment)

    4/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    10/20/23 1:07:25 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Gonsalves Rodney bought $288 worth of shares (3 units at $111.09), increasing direct ownership by 0.01% to 24,222 units (SEC Form 4)

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    9/29/23 4:03:46 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hadron Energy Unveils Distinguished Board of Directors to Lead the Company Following the deSPAC with GigCapital7 Into Proposed $1.2B Public Listing

    Hadron Energy, Inc. ("Hadron") proudly announces the designated nominees for its seven-member Board of Directors (BOD), a leadership body composed of some of the most accomplished figures in nuclear energy, public policy, advanced technology, regulatory governance, and public-company operations. Designated ahead of Hadron's proposed $1.2 billion public listing through its definitive business combination with GigCapital7 Corp. (NASDAQ:GIG), the BOD brings together unmatched expertise essential for guiding America's next generation of nuclear deployment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251201658946/en/Figure 1: Hadro

    12/1/25 8:05:00 AM ET
    $COLM
    $GIG
    $GIW
    Apparel
    Consumer Discretionary
    Blank Checks
    Finance

    Agilent Announces 21 CFR Part 11 Compliance Software for xCELLigence RTCA eSight

    Agilent Technologies Inc (NYSE:A) today announced the release of a new 21 CFR Part 11 compliance software for the Agilent xCELLigence Real-Time Cell Analysis (RTCA) eSight system. The software includes a compliance license and enhanced security features, allowing this multiplex live-cell analysis system to be deployed not only in drug discovery and development labs but now also in GMP-regulated manufacturing and quality control settings. Extending the platform's use across the pharma and biopharma value chain will help support continuity from early-stage drug discovery and research to production. The new software is designed to address a rising demand for regulatory-ready digital lab tools

    12/1/25 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results

    Delivers solid results in Q4, initiates FY26 guidance Fourth-quarter fiscal year 2025 Revenue of $1.86 billion for the fourth quarter ended October 31, 2025, exceeding revenue guidance and representing growth of 9.4% reported and up 7.2% on a core(1) basis compared with the fourth quarter of 2024. GAAP net income of $434 million; earnings per share (EPS) of $1.53, up 25% from the fourth quarter of 2024. Non-GAAP(2) net income of $452 million; EPS of $1.59, up 9% from the fourth quarter of 2024. Full fiscal year 2025 Revenue of $6.95 billion for the fiscal year ended October 31, 2025, exceeding revenue guidance and representing growth of 6.7% on a reported basis and up 4.9% on a c

    11/24/25 4:10:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Dolsten Mikael sold $389,511 worth of shares (2,600 units at $149.81), decreasing direct ownership by 34% to 4,973 units (SEC Form 4)

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    12/3/25 4:04:44 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Senior Vice President Zhang Jianmiao Mike covered exercise/tax liability with 208 shares, decreasing direct ownership by 2% to 11,639 units (SEC Form 4)

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    12/1/25 4:36:53 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Senior Vice President Riemann Angelica covered exercise/tax liability with 280 shares, decreasing direct ownership by 1% to 26,594 units (SEC Form 4)

    4 - AGILENT TECHNOLOGIES, INC. (0001090872) (Issuer)

    12/1/25 4:35:47 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Agilent with a new price target

    Goldman initiated coverage of Agilent with a rating of Buy and set a new price target of $170.00

    12/9/25 8:42:01 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Morgan Stanley initiated coverage on Agilent with a new price target

    Morgan Stanley initiated coverage of Agilent with a rating of Overweight and set a new price target of $270.00

    12/2/25 8:23:20 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Rothschild & Co Redburn initiated coverage on Agilent with a new price target

    Rothschild & Co Redburn initiated coverage of Agilent with a rating of Buy and set a new price target of $165.00

    10/8/25 8:31:21 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $UPST
    $TGH
    $A
    $TLGA
    SEC Filings

    View All

    Agilent Technologies Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - AGILENT TECHNOLOGIES, INC. (0001090872) (Filer)

    11/24/25 4:11:19 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 144 filed by Upstart Holdings Inc.

    144 - Upstart Holdings, Inc. (0001647639) (Subject)

    11/20/25 4:54:00 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    SEC Form 144 filed by Upstart Holdings Inc.

    144 - Upstart Holdings, Inc. (0001647639) (Subject)

    11/20/25 4:51:42 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    $UPST
    $TGH
    $A
    $TLGA
    Leadership Updates

    Live Leadership Updates

    View All

    Agilent Names Adam S. Elinoff as Chief Financial Officer

    Agilent Technologies Inc. (NYSE:A) today announced the appointment of Adam S. Elinoff as chief financial officer, effective Nov. 17. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251027719923/en/Adam S. Elinoff, Chief Financial Officer, Agilent Technologies Elinoff brings two decades of financial experience spanning corporate finance, investor relations, strategy and business transformation, and has a proven record of driving enterprise-wide transformations, optimizing financial operations and scaling global capabilities. He joins Agilent from Amgen, a worldwide pioneer in biotechnology, where he advanced through a series of

    10/27/25 4:15:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Agilent Showcases Solutions and Partnerships Transforming Cancer Research and Therapeutics at AACR 2025

    Agilent Technologies Inc. (NYSE:A) announced today its participation at the American Association for Cancer Research (AACR) Annual Meeting on April 25-30, 2025 in Chicago, Illinois. Innovative Agilent products and partnerships playing a crucial role in transforming cancer research, diagnostics, and therapeutics will be featured, including: Agilent Avida DNA Cancer Panels – Based on cutting-edge next-generation sequencing (NGS) target enrichment solutions that enable simultaneous DNA and methylation profiling from a single sample, the Avida product portfolio has expanded to include three new DNA panels*. Optimized based on the requirements of the European OncNGS Consortium, these catalog p

    4/24/25 8:00:00 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Broadway Financial Corporation Announces New Board Member

    LOS ANGELES, March 10, 2025 /PRNewswire/ -- Broadway Financial Corporation ("Broadway" or the "Company") (NASDAQ:BYFC), parent company of City First Bank, National Association (the "Bank"), is pleased to announce the appointment of Mary Hentges to its board of directors (the "Board"), effective March 5, 2025, to fill the vacancy on the Board after its size was increased to ten directors. Ms. Hentges will serve on the Audit Committee of the Board of the Company and the Bank, and on the Risk and Compliance Committee and Internal Asset Review Committee of the Bank. Ms. Hentges wi

    3/10/25 5:25:00 PM ET
    $BYFC
    $UPST
    Savings Institutions
    Finance
    Finance: Consumer Services

    $UPST
    $TGH
    $A
    $TLGA
    Financials

    Live finance-specific insights

    View All

    Agilent Reports Fourth-Quarter Fiscal Year 2025 Financial Results

    Delivers solid results in Q4, initiates FY26 guidance Fourth-quarter fiscal year 2025 Revenue of $1.86 billion for the fourth quarter ended October 31, 2025, exceeding revenue guidance and representing growth of 9.4% reported and up 7.2% on a core(1) basis compared with the fourth quarter of 2024. GAAP net income of $434 million; earnings per share (EPS) of $1.53, up 25% from the fourth quarter of 2024. Non-GAAP(2) net income of $452 million; EPS of $1.59, up 9% from the fourth quarter of 2024. Full fiscal year 2025 Revenue of $6.95 billion for the fiscal year ended October 31, 2025, exceeding revenue guidance and representing growth of 6.7% on a reported basis and up 4.9% on a c

    11/24/25 4:10:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Agilent Announces Cash Dividend of 25.5 Cents Per Share

    Agilent Technologies Inc. (NYSE:A) today announced a quarterly dividend of 25.5 cents per share of common stock. The quarterly dividend will be paid on Jan. 28, 2026, to all shareholders of record as of the close of business on Jan. 6, 2026. The timing and amounts of future dividends are subject to the determination and approval by Agilent's board of directors. About Agilent Technologies Agilent Technologies Inc. (NYSE:A) is a global leader in analytical and clinical laboratory technologies, delivering insights and innovation that help our customers bring great science to life. Agilent's full range of solutions includes instruments, software, services, and expertise that provide trust

    11/19/25 4:15:00 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Upstart Announces Results for Third Quarter 2025

    Upstart Holdings, Inc. (NASDAQ:UPST), the leading artificial intelligence (AI) lending marketplace, today announced financial results for the quarter ended September 30, 2025. Upstart will host a conference call and webcast at 1:30 p.m. Pacific Time today. An earnings presentation and link to the webcast are available at ir.upstart.com. "In Q3, we continued to execute on our 2025 game plan of rapid growth, profitability, and AI leadership — all anchored in exceptional credit performance. The results include 80% year-on-year growth in originations with 71% growth in revenue, and a sixfold sequential increase in GAAP net income," said Dave Girouard, Co-founder and CEO of Upstart. "Our AI pla

    11/4/25 4:05:00 PM ET
    $UPST
    Finance: Consumer Services
    Finance

    $UPST
    $TGH
    $A
    $TLGA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Agilent Technologies Inc.

    SC 13G/A - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 1:27:37 PM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/12/24 11:54:03 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form SC 13G filed by Agilent Technologies Inc.

    SC 13G - AGILENT TECHNOLOGIES, INC. (0001090872) (Subject)

    11/4/24 10:57:57 AM ET
    $A
    Biotechnology: Laboratory Analytical Instruments
    Industrials